CODEXIS, INC.
جودة البيانات: 100%
CDXS
NASDAQ
Manufacturing
Chemicals
KWD 2.24
▼
KWD 0.16
(-6.67%)
القيمة السوقية: 209.91 M
السعر
KWD 2.31
القيمة السوقية
209.91 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—
Quick Summary
النقاط الرئيسية
Revenue declined -9.46% annually over 5 years
Negative free cash flow of -23.85 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 28.07%
Capital efficient — spends only 6.35% of revenue on capex
النمو
Revenue Growth (5Y)
-9.46%
أقل من متوسط القطاع (1.82%)
Revenue (1Y)18.61%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-93.39%
أقل من متوسط القطاع (-54.01%)
ROIC-28.86%
Net Margin-62.47%
Op. Margin-59.30%
الأمان
Debt / Equity
1.03
أعلى من متوسط القطاع (0.30)
Current Ratio4.12
Interest CoverageN/A
التقييم
PE (TTM|NTM)
-4.77 | -10.18
أقل من متوسط القطاع (-1.49)
P/B Ratio5.45
EV/EBITDAN/A
Dividend YieldN/A
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1385 نظير)
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1385 نظير)| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -4.8 | -1.5 |
| P/B | 5.5 | 1.6 |
| ROE % | -93.4 | -54.0 |
| Net Margin % | -62.5 | -41.5 |
| Rev Growth 5Y % | -9.5 | 1.8 |
| D/E | 1.0 | 0.3 |
السعر المستهدف للمحللين
6 محللين
Buy
الحالي
KWD 2.24
المستهدف
KWD 6.58
KWD 2.00
KWD 7.00
KWD 11.00
التوقعات
مكرر الربحية المستقبلي
-10.18
ربحية السهم المستقبلية
-KWD 0.22
الإيرادات المقدّرة
89.87 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
-KWD 0.22
-KWD 0.38 – -KWD 0.06
|
89.87 M | 2 |
| FY2026 |
-KWD 0.32
-KWD 0.46 – -KWD 0.21
|
74.34 M | 3 |
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| 2026 Q2 |
-KWD 0.11
-KWD 0.14 – -KWD 0.07
|
16.61 M | 2 |
| 2026 Q1 |
-KWD 0.11
-KWD 0.13 – -KWD 0.08
|
14.44 M | 2 |
مفاجآت الأرباح
آخر 4 أرباع
| الربع | EPS المقدر | EPS الفعلي | المفاجأة |
|---|---|---|---|
| Q42025 | -KWD 0.04 | KWD 0.14 | +508.6% |
| Q32025 | -KWD 0.13 | -KWD 0.22 | -73.7% |
| Q22025 | -KWD 0.15 | -KWD 0.16 | -6.7% |
| Q12025 | -KWD 0.21 | -KWD 0.25 | -20.5% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 18.61% | Revenue Growth (3Y) | 0.17% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -9.46% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 70.39 M | Net Income (TTM) | -43.97 M |
| ROE | -93.39% | ROA | -33.54% |
| Gross Margin | N/A | Operating Margin | -59.30% |
| Net Margin | -62.47% | Free Cash Flow (TTM) | -23.85 M |
| ROIC | -28.86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.03 | Current Ratio | 4.12 |
| Interest Coverage | N/A | Asset Turnover | 0.54 |
| Working Capital | 57.72 M | Tangible Book Value | 36.08 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -4.77 | Forward P/E | -10.18 |
| P/B Ratio | 5.45 | P/S Ratio | 2.98 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 2.34 | Fwd Earnings Yield | N/A |
| FCF Yield | -11.36% | ||
| Market Cap | 209.91 M | Enterprise Value | 224.29 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.50 | Revenue / Share | 0.77 |
| FCF / Share | -0.26 | OCF / Share | -0.21 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 6.35% | FCF Conversion | 54.23% |
| SBC-Adj. FCF | -33.98 M | Growth Momentum | 28.07 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 70.39 M | 59.35 M | 70.14 M | 138.59 M | 104.75 M |
| Net Income | -43.97 M | -65.28 M | -76.24 M | -33.59 M | -21.28 M |
| EPS (Diluted) | -0.50 | -0.89 | -1.12 | -0.51 | -0.33 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -41.74 M | -58.52 M | -68.07 M | -34.88 M | -22.70 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 52.31 M | 46.26 M | 58.89 M | 80.10 M | 55.92 M |
| SG&A Expenses | 47.07 M | 55.15 M | 53.25 M | 52.17 M | 49.32 M |
| D&A | 5.25 M | 4.95 M | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | 47,000.0 | 34,000.0 | 69,000.0 | 276,000.0 | 189,000.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 147.80 M | 149.01 M | 136.56 M | 250.39 M | 246.38 M |
| Total Liabilities | 97.27 M | 82.08 M | 49.95 M | 105.60 M | 81.99 M |
| Shareholders' Equity | 50.53 M | 66.93 M | 86.62 M | 144.80 M | 164.39 M |
| Total Debt | 40.11 M | 28.91 M | — | — | — |
| Cash & Equivalents | 50.79 M | 19.26 M | 65.12 M | 113.98 M | 116.80 M |
| Current Assets | 96.82 M | 98.77 M | 93.47 M | 162.89 M | 161.89 M |
| Current Liabilities | 25.32 M | 23.65 M | 35.83 M | 49.07 M | 33.37 M |
{"event":"ticker_viewed","properties":{"ticker":"CDXS","listing_kind":"stock","pathname":"/stocks/cdxs","exchange":"NASDAQ","country":"US"}}